Sichuan Kelun Pharmaceutical Co., Ltd. (002422) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sichuan Kelun Pharmaceutical Co., Ltd.

Why is Sichuan Kelun Pharmaceutical Co., Ltd. ?

The company has declared Negative results for the last 6 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at CNY 2,608.1 MM
NET PROFIT(9M) At CNY 1,141.6 MM has Grown at -32.93%
ROCE(HY) Lowest at 6.58%

Underperformed the market in the last 1 year

The stock has generated a return of 7.83% in the last 1 year, much lower than market (China Shanghai Composite) returns of 23.91%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sichuan Kelun Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Sichuan Kelun Pharmaceutical Co., Ltd.

7.83%

0.40

37.77%

China Shanghai Composite

21.43%

1.73

13.79%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

1.48%

EBIT Growth (5y)

4.76%

EBIT to Interest (avg)

9.46

Debt to EBITDA (avg)

1.25

Net Debt to Equity (avg)

-0.08

Sales to Capital Employed (avg)

0.74

Tax Ratio

22.04%

Dividend Payout Ratio

55.51%

Pledged Shares

Institutional Holding

ROCE (avg)

11.99%

ROE (avg)

10.61%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.61

EV to EBIT

21.58

EV to EBITDA

13.00

EV to Capital Employed

1.76

EV to Sales

1.90

PEG Ratio

Dividend Yield

3.62%

ROCE (Latest)

8.14%

ROE (Latest)

6.79%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

CASH AND EQV(HY)

Highest at CNY 16,392.3 MM

DEBT-EQUITY RATIO (HY)

Lowest at -17.19 %

-18What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 2,608.1 MM

NET PROFIT(9M)

At CNY 1,141.6 MM has Grown at -32.93%

ROCE(HY)

Lowest at 6.58%

INTEREST(Q)

At CNY 23.12 MM has Grown at 21.07%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,155.43

PRE-TAX PROFIT(Q)

At CNY 374.69 MM has Fallen at -47%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.61 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.9 times

OPERATING PROFIT(Q)

Lowest at CNY 267.09 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 6.27 %

Here's what is working for Sichuan Kelun Pharmaceutical Co., Ltd.

Cash and Eqv

Highest at CNY 16,392.3 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -17.19 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Sichuan Kelun Pharmaceutical Co., Ltd.

Net Profit

At CNY 1,141.6 MM has Grown at -32.93%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 2,608.1 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

At CNY 23.12 MM has Grown at 21.07%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 1,155.43

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

At CNY 374.69 MM has Fallen at -47%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Operating Profit

Lowest at CNY 267.09 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 6.27 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 2.61 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.9 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Non Operating Income

Highest at CNY 0.34 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income